(Q58493754)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

endometrial carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Maria Fasero

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

J A Vidart

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J A Lopez-asenjo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

V Furio-bacete

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Magrina

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Escudero

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Obstetrics Gynecology and Reproductive Biology

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

103-108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

The prognostic significance of surgical staging for carcinoma of the endometrium

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Risk factors and recurrent patterns in Stage I endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Carcinoma of the endometrium: Effect of stage and grade on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Prognostic factors in early carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Peritoneal cytology in patients with endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Prognostic significance of p53, bcl-2, vimentin, and S100 protein-positive Langerhans cells in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

The neu oncogene encodes an epidermal growth factor receptor-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Endometrial carcinoma: immunohistochemically detected proliferation index is a prognosticator of long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Clinicopathological characteristics of p53 overexpression in endometrial cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Loss of p53 function in uterine papillary serous carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Proliferative and apoptotic status in endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Expression and mutation analysis of the p53 gene in uterine papillary serous carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

p53 protein overexpression in early stage endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

HER-2/neu, p53, and DNA analyses as prognosticators for survival in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

HER-2/neu expression: a major prognostic factor in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900562-5

7 January 2021

10.1016/S0301-2115(00)00562-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference